Загрузка...
Tiotropium formulations and safety: a network meta-analysis
Tiotropium is now delivered via two different inhaler devices: the original Handihaler 18 μg once daily, which uses a powder formulation; and the newer Respimat Soft Mist Inhaler (SMI) 5 μg once daily. It has been questioned whether the two devices can be assumed to have the same safety profile, alt...
Сохранить в:
| Опубликовано в: : | Ther Adv Drug Saf |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5298465/ https://ncbi.nlm.nih.gov/pubmed/28203364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098616667304 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|